Home Blog Page 362

Millennium Trust’s Auto Portability Functionality Ready for Client Testing in June

0
Millennium Trust’s Auto Portability Functionality Ready for Client Testing in June
Network will be open to clients, other portability networks


Millennium Trust Company

Millennium Trust Company logo

Millennium Trust Company, LLC, a leading provider of health, wealth, retirement, and benefits solutions, today announced it soon will offer optional auto portability functionality for its best-in-class automatic rollover IRA solution. 

The functionality is designed to connect to existing and new auto portability networks in order to further the industry's ongoing efforts to reduce retirement savings leakage and increase access for all. This new, add-on feature will be ready for client testing later this quarter and available to go live in 2024.

"Thousands of recordkeepers, third-party administrators and plan sponsors - including more than half of the top 20 recordkeepers - partner with Millennium Trust to decrease leakage. Our scale and existing technology integrations put us in the unique position to connect the industry, and we knew we could bring this functionality to market quickly," said Erik Beck, Chief Commercial Officer of Millennium Trust. "We're offering this optional feature so any clients interested in connecting with our extensive network of retirement industry participants will be able to do so quickly and easily."

Millennium Trust's automatic rollover solution has always supported active portability of an IRA owner's funds when the account owner chooses to do so, and now the company is improving and extending the solution's portability options. This current initiative is part of Millennium Trust's more than $30 million commitment to combat retirement savings leakage by reducing friction, expanding access to savings options, and providing more financial education. 

Beck said the company is engaged in extensive, ongoing dialogue with clients of all sizes about their needs. Millennium Trust will have the new functionality in place by the end of June 2023, so anyone interested in the feature will be able to first test it and then implement it at no additional cost on Jan. 1, 2024. 

Auto portability leverages the core features of Millennium Trust's automatic rollover solution, helping individuals transfer their retirement savings from a former employer's retirement plan to an automatic rollover IRA, and then to their new 401(k) or similar employer-sponsored retirement plan unless they elect otherwise. It is an optional add-on to the existing automatic rollover solution, wherein low-balance accounts of non-responsive former employees are rolled over to an IRA to maintain the tax advantages of the retirement savings system and reduce leakage. 

The SECURE 2.0 Act of 2022 allows Millennium Trust to offer auto portability services to recordkeepers, third-party administrators and plan sponsors of all sizes. Auto portability is not mandatory. Rather, plan sponsors may choose to add auto portability to their existing automatic rollover solution, whether through Millennium Trust or another provider, thanks to Millennium Trust's open network approach to this functionality.

"Millennium Trust wants to make a broad impact on keeping money in the retirement system by partnering with recordkeepers, third-party administrators, plan sponsors and others in our industry. We welcome any current and future retirement industry providers to join us in this mission," Millennium Trust CEO Dan Laszlo said. "No matter the size of the partner, we want to provide a no-cost, fast and easy option to connect so they can offer their clients choice. And we won't stop there. We will continue to work on health and wealth solutions that help individuals long before and well into retirement."

About Millennium Trust Company

Millennium Trust Company solves important business challenges through innovative financial wellness solutions that help people plan, save and invest. With more than 5 million clients holding over $55 billion in assets under custody, we are committed to using our decades of expertise and strong partnership with the financial community to empower employers, advisors and institutions to help people achieve short-term and long-term financial security. Learn more at mtrustcompany.com.

Contact Information:
Emily Burns Perryman
Manager, PR & Communications
[email protected]
847-594-0859


Original Source: Millennium Trust's Auto Portability Functionality Ready for Client Testing in June

Air Review

0
Air Review

We review Ben Affleck’s excellent Nike drama Air, starring Matt Damon.

PLOT: In 1984, Nike executive Sonny Vaccaro (Matt Damon) tries to recruit Michael Jordan as a Hail Mary to save the fledgling basketball shoes division.

REVIEW: Ben Affleck’s Air allows the director to play to all his strengths as a director and actor. Like Argo, it shines a light on an intriguing event from the eighties, but unlike that film, the stakes here aren’t necessarily life and death. But, if you think the idea of a movie about Michael Jordan being signed to Nike is minor, you’d be wrong, as this is a truly involving, entertaining depiction of everything that went into the landmark deal. And this deal forever changed the way athletes are compensated the world over.

Matt Damon is at his best as the plucky Vaccaro. A passionate devotee of the game, he’s trying to put Nike on the map amongst basketball players at a time when Nike, as crazy as it sounds, was unhip. Converse was the biggest sneaker, and Adidas was quickly gaining momentum as the “cool” brand thanks to having placement in hip-hop videos. The movie spends much time depicting the frustration of all involved, who know they have the superior product. In addition to Damon’s Vaccaro, there’s Jason Bateman as Rob Strasser, who’s in charge of marketing and has his family’s future staked on the shoe’s success.

In a showy supporting role, there’s also Ben Affleck himself as Phil Knight, Nike’s colourful CEO, who wears a perm and shows up to the office wearing loud tracksuits. While he initially comes off as a bit of an eighties yuppie send-up, Knight is also depicted as savvy and someone who believes in his employees, particularly Vaccaro, whose gambles often don’t pay off.

The movie follows Damon’s affable Vaccaro as he puts his and the company’s future on the line in his aggressive pursuit of Jordan. Remember that no one had any inkling of what MJ would become at the time, so it was a significant gamble. While we all know the outcome, we don’t know what went into the deal, with much time spent on Vaccaro’s respectful relationship with Jordan’s business-savvy mother, Deloris (played but the great Viola Davis), who wants her son to get his rightful share of whatever profits are made off of his name.

Affleck does a good job evoking the eighties era in a way that this actually feels like a movie that legitimately could have been made in the decade. The film is shot in a way that evokes an older-type movie by Robert Richardson, and Affleck even got Tangerine Dream to work on the score. Notably, the pace is kept tight, with the film running a lean, disciplined 112 minutes, with no fat on the bone whatsoever.

Affleck really has made a movie that sits nicely on the shelf next to Argo, and it seems sure to be a crowd-pleaser, even if you’re not a sports fan. The acting is top shelf, not only from Damon and Affleck, who are well-served by writer Alex Convery’s dialogue but also the entire supporting cast. That includes Chris Messina as Jordan’s shark-like (but not cartoonish agent). In a single scene, Marlon Wayans as college coach George Raveling, delivers the movie’s standout monologue about why you should always listen to your intuition. Chris Tucker is also terrific in an atypical role as Howard White, the man in charge of player relations, who evokes a believable affability that hides his own desire to do right by the families he interacts with.

All in all, Air really is a terrific package, with Affleck having a ton of fun telling this story. It definitely has one of the best soundtracks of the year, with the needle drops running the gamut from Bruce Springsteen to Axel F. Affleck even repurposes Pino Donaggio’s main theme to Brian De Palma’s Body Double to complement the Tangerine Dream music. It’s a nice touch in a movie that’s full of them. While Air will bow on Prime Video within a few months, it’s definitely a movie that delivers on the big screen and a rare adult drama people should go out and support.

8

Originally published at https://www.joblo.com/air-review/

Nutrition21 to Showcase Lustriva at NYSCC Supplier’s Day Show

0
Nutrition21 to Showcase Lustriva at NYSCC Supplier’s Day Show

Nutrition21 LLC will be exhibiting at the New York Society of Cosmetic Chemists (NYSCC) "Suppliers' Day 2023" show (booth #116) at the Jacob Javitz Convention Center in New York City May 2-3, 2023. The company will be featuring its newest patented beauty-from-within ingredient Lustriva®.

While conventional biotin is often used in beauty supplements, its benefits are vague. Lustriva is a clinically substantiated patented complex that combines Bonded Arginine Silicate with Magnesium Biotinate to promote healthier-looking hair and skin.*

Lustriva is unique in that it significantly increases biotin solubility 40 times greater than that of D-biotin, the form of this vitamin commonly found in beauty products. 

In a clinical study1, healthy women who received Lustriva experienced thicker hair as well as a nearly 20% increase in hair growth in as little as three weeks. In the same study, participants also experienced improved skin texture and a 10% reduction in the appearance of wrinkles in just 12 weeks.

According to Catherine Kwik-Uribe, Ph.D., Nutrition21's Vice President of Scientific and Regulatory Affairs, "There are many options in the market today. The research shows that Lustriva's unique formulation offers 2-in-1 benefits that you can see and feel. 

"Fortunately, the science and technology behind Lustriva offers formulators the assurance they need that the right forms of biotin and silicon make all the difference; the highly bioavailable forms of silicon and biotin can only be found in this product."

Lustriva is self-affirmed Generally Recognized As Safe (GRAS) status and can be easily incorporated into a variety of products, including dietary supplements, functional foods, gummies and gels, and ready-to-drink beverages in a small clinical dose of 160 mg.

Information on registering for the event can be found here

About Lustriva® 

Lustriva® is a patented complex of Bonded Arginine Silicate and Magnesium Biotinate that is designed as a healthy aging ingredient. Lustriva is unique in that its form of biotin has 40X greater solubility than D-biotin and offers proven bioavailable forms of biotin and silicon. Lustriva has multiple benefits for hair and skin and has been clinically shown to increase hair growth in as little as three weeks and reduce wrinkles and improve skin's texture within 12 weeks.

For more information on Lustriva, visit https://nutrition21.com/lustriva/.

About Nutrition21, LLC

Nutrition21 is an industry-leading developer and marketer of efficacious, high-value, clinically substantiated ingredients for use in dietary supplements, functional foods and beverages. With decades of experience, the company's scientific platform has continued to create unique, patented products that are both safe and clinically effective. To build consumer trust, Nutrition21 ensures product efficacy and safety through a product development process that involves rigorous preclinical and clinical research. The company currently holds over 70 domestic and international issued and pending patents for its ingredients which support unique claims associated with sports nutrition, weight management, cognitive health, and beauty-from-within, among others.

For more information on Nutrition21, visit www.Nutrition21.com.

[1] Kalman DS and Hewlings SJ. A randomized double-blind evaluation of a novel biotin and silicon ingredient complex on the hair and skin of healthy women. J Clin Exp Dermatol Res. 2021;12(1):1-7. Accessed April 9, 2023.

*These statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose, treat, cure or prevent any disease.

©2023 Nutrition21, LLC 

Nutrition21, LLC, Saddle Brook, NJ Source: Nutrition21, LLC M0002423

Contact Information:
Becky Wright
Media Contact
[email protected]
201-675-0197


Original Source: Nutrition21 to Showcase Lustriva at NYSCC Supplier's Day Show

The Boys: Jensen Ackles to appear as Soldier Boy in Gen V spinoff series

0
The Boys: Jensen Ackles to appear as Soldier Boy in Gen V spinoff series

Jensen Ackles says that he will appear as Soldier Boy in Gen V, Prime Video’s upcoming spinoff of The Boys.

Jensen Ackles joined The Boys last season to play Soldier Boy, America’s first and greatest superhero, and it sounds as though he’ll make an appearance in the upcoming spinoff series Gen V as well.

While speaking with fans during a Creation New Orleans convention (via Entertainment Weekly), Jensen Ackles revealed that his character of Soldier Boy will show up in Gen V. “Soldier Boy pops up for a brief moment in this new spin-off of The Boys,” Ackles said. “In fact, there’s a few cameos from the mothership that come into this spin-off. My little bit there was heavily [improvised].” Ackles added that The Boys showrunner Eric Kripke was on set with him for filming. “He and I were just, like, we were spitballing ideas and workshopping literally in between takes and coming up with a whole variety of takes,” Ackles said.

Gen V takes place “in America’s only college exclusively for young adult superheroes (or supes) that is run by Vought International.” It will explore the lives of “hormonal, competitive supes as they put their physical, sexual, and moral boundaries to the test, competing for the best contracts in the best cities. Part college show, part Hunger Games—with all the heart, satire, and raunch of The Boys.

Eric Kripke has previously teased that Gen V would include a few crossovers with The Boys, both in terms of characters and events. “There’s definitely crossover, and we’re doing our best to design a universe that sees some of the issues and storylines in Season 3 hand off to the first season in Varsity,” Kripke said. “Like there’s a presidential campaign happening in the background of that season, and there’s certain things that are happening at that school that are both in reaction to Season 3 of The Boys. There’s Soldier Boy, etcetera, but also some new storylines that are happening in that season of the spinoff that we have to pick up and take into Season 4 of the show.” We don’t have an official release date for Gen V yet, but the spinoff series is expected to premiere on Prime Video sometime this year.

https://www.youtube.com/watch?v=O9tOac2i45c

Originally published at https://www.joblo.com/jensen-ackles-soldier-boy-gen-v-the-boys/

Carebox and the American Cancer Society Cancer Action Network are Piloting Clinical Trial Matching at the Point of Care

0
Carebox and the American Cancer Society Cancer Action Network are Piloting Clinical Trial Matching at the Point of Care
Pilot of EHR-embedded clinical trial matching to enhance diversity in cancer research set to begin at two hospital systems in Texas and West Virginia.


Carebox

Carebox connects patients and physicians seeking treatment options with clinical trials.

Carebox, a leading provider of clinical trial matching solutions, today announced its participation in the launch of the "Blue-button" Matching Project of the American Cancer Society Cancer Action Network (ACS CAN).

The Blue-button tool automatically identifies relevant clinical trials through one-button clinical trial matching integration within electronic health records (EHRs). It puts clinical trial matching into the workflow of treating physicians via automated matching and pre-screening of clinical trials based on the patient record being viewed. This automated matching can surface the hospital system's own portfolio of clinical trials, as well as optionally matching trials within a specified distance from where the patient is located.

ACS CAN has announced that the Blue-button tool will now be piloted with over 500 patients at the University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center - an urban, academic center - and West Virginia University Cancer Institute, a rural, multi-site community system. The pilot will evaluate whether the tool can increase and diversify trial participation with minimal effort on the part of providers.

Carebox is one of several vendors that will be providing matching technology to ACS CAN for this project. Carebox is the only participating vendor that covers not only all cancer types but also tens of other conditions in its clinical trial matching engine.

"We're very pleased to be able to incorporate Carebox's long-tested matching technology and its ability to provide trial choices to the patients into this pilot, " said Mark Fleury, Ph.D., Policy Principal for ACS CAN and lead investigator on the project.

"The robust platform architecture of Carebox Connect allowed us to take the same matching engine used by over one million patients in our solutions for trial sponsors, patient advocacy groups, and the Carebox Connect web application (https://connect.careboxhealth.com) and make it available as a stand-alone API that supports the HL7® Fast Healthcare Interoperability Resources (FHIR®) standard used by EHRs," explained Shaike Marc, Carebox VP of Technology. Carebox is working with several partners to pilot the integration of trial matching into a wide range of digital health application contexts.

Carebox Connect for Sites is used by leading hospital research centers such as UCLA Health across all disease areas being researched, as well as with leading cancer centers such as the Abramson Cancer Center at Penn Medicine and the Moffitt Cancer Center. It enables them to engage, educate, navigate, match, and refer patients and treating physicians to the clinical trial study teams in their centers more effectively. 

"We believe that bringing trial matching into the workflow of treating physicians at the point of care will add an important additional dimension to Carebox Connect for Sites," noted Brian Weiss, Carebox CEO. "It will allow research centers to optimize trial recruitment and enhance participant diversity in support of ongoing clinical research. We are proud and excited to be working with ACS CAN on this strategic initiative to evolve and validate this capability."

About Carebox

Carebox connects patients and physicians seeking treatment options with clinical trials. For patients and families, access to information about the newest and most advanced treatment options is obscured and frustrating to find. For pharma companies, clinical trial recruitment is the primary bottleneck in the $100B+ drug development market now being reshaped by precision medicine treatment specificity, new trial models, diversity requirements, and digital health consumer expectations. Carebox is at the forefront of addressing these challenges for patients and their families, as well as for the ecosystem of companies involved in sponsoring, running, and recruiting for clinical trials. 

Learn more about Carebox at https://careboxhealth.com.

About Carebox Connect

The Carebox Connect cloud platform digitizes Carebox's two decades of experience in navigating over one million patients seeking clinical trial options. It enables trial sponsors of all sizes to educate, engage, navigate, match, qualify, refer, and enroll patients in their clinical trials. Pharma trial sponsors, hospital research centers, and patient advocacy groups use Carebox Connect to present their clinical trial portfolios to the public, optimize trial recruitment, and enhance participant diversity in support of ongoing clinical research.

Contact Information:
Karen Shemesh
Marketing
[email protected]
1-866-914-7345


Original Source: Carebox and the American Cancer Society Cancer Action Network are Piloting Clinical Trial Matching at the Point of Care

NuEyes Enters Into Multiyear Strategic Distribution Agreement With Innovative Optics

0
NuEyes Enters Into Multiyear Strategic Distribution Agreement With Innovative Optics

NuLoupes

Front View

NuEyes, a pioneer in the field of augmented reality smart glass technology is happy to announce that they have executed a multiyear exclusive distribution agreement with Innovative Optics, an industry-leading medical device company, to address the Dermatology, Plastic Surgery, Aesthetics, and Industrial Facility market with NuLoupes.

The multiyear distribution agreement is for a minimum order quantity of 24,000 NuLoupes and addresses the needs of plastic surgeons and dermatologists not only in the operating room but in their daily practices. NuLoupes complements Innovative Optics' current lineup of laser safety and loupe products in expanding their current line of the highest quality laser protection. NuLoupes brings surgical loupes into the 21st century with its revolutionary technology and ecosystem for medical professionals. Moving from traditional fixed magnification to the NuLoupes high-resolution 3D variable digital magnification will provide surgeons with more versatility and viewing area. 

"Andy and his team are at the forefront of technology in these sectors, offering the highest quality safety solutions available. They will do an outstanding job communicating and distributing cutting-edge technology such as NuLoupes," said Mark Greget, founder and CEO of NuEyes. "I feel confident that they will do an outstanding job representing NuLoupes and all its capabilities."

"Partnering with NuEyes to help give critical user feedback to NuLoupes was the start of an amazing journey into helping doctors improve the lives of others. We are thrilled to be a part of this revolutionary technology, and we can't wait to begin bringing it to these markets later in the year. Based on anticipated expert feedback, we think this multiyear commitment is the minimum potential in the verticals we serve," said Andy Barrows, CEO of Innovative Optics. 

ABOUT INNOVATIVE OPTICS

Innovative Optics was established in 1993 with a focus on manufacturing high-quality specialized laser safety products. As both thought leaders and innovators in the industry, their line of laser safety items includes laser protection, IPL protection, patient goggles, disposable eye shields, and laser barriers. They're here to help educate and determine the best safety solutions to fit your needs.

ABOUT NUEYES TECHNOLOGIES INC.

NuEyes is a veteran-owned smart glass technology company based in Orange County, California, that was launched in January 2016 to assist those with eye conditions such as macular degeneration, glaucoma, and retinitis pigmentosa. Over the past seven years, the company has seen extensive sales growth and has obtained Federal, State, and Insurance reimbursement for its devices. NuEyes addresses a multitude of augmented reality markets including low vision and medical, enterprise, gaming, and entertainment. With the leadership of NuEyes having over 20 years of combined experience in this space, they understand what it takes to successfully bring a new product to market.

Website: www.nueyes.com

Contact Information:
Regina Chatman
Director, Sales and Marketing
[email protected]
800-605-4033


Original Source: NuEyes Enters Into Multiyear Strategic Distribution Agreement With Innovative Optics

Joker 2 has wrapped as Todd Phillips shares new looks at Joaquin Phoenix, Lady Gaga

0
Joker 2 has wrapped as Todd Phillips shares new looks at Joaquin Phoenix, Lady Gaga

Todd Phillips took to Instagram to announce that Joker 2 has finally wrapped after four months of filming. The director also shared two new images from the movie featuring Joaquin Phoenix and Lady Gaga in character. “That’s a wrap,” Phillips wrote in the caption. “Thanks to these two (+ the entire cast) and the BEST crew that the film industry has to offer. From top to bottom. Gonna crawl into a cave now (edit room) and put it all together.

Joker: Folie à Deux will find Joaquin Phoenix (Beau is Afraid) reprising his role of Arthur Fleck, with Lady Gaga (House of Gucci) starring alongside him as Harley Quinn. Zazie Beetz (Deadpool 2) has also returned to reprise her role of Sophie Dumond from the first movie. The rest of the cast consists of Brendan Gleeson (The Banshees of Inisherin), Catherine Keener (The Adam Project), Jacob Lofland (The Son), and Harry Lawtey (The Pale Blue Eye).

Once the first Joker movie became the first R-rated movie to gross over $1 billion worldwide — not to mention earning Joaquin Phoenix the Academy Award for Best Actor — it was only a matter of time before the studio got the ball rolling on a sequel. But the new film won’t be part of the new DC Universe taking shape under the leadership of James Gunn and Peter Safran, as it will fall under the DC Elseworlds label which would also include Matt Reeves’ The Batman – Part II.

Much of Joker: Folie à Deux is expected to take place in Arkham Asylum, which is where we left Arthur Fleck in the last movie. The film has also been described as something of a musical, which has certainly piqued my interest. Although Joker 2 may have wrapped, we still have quite a wait ahead of us as the sequel isn’t set to be released until October 4, 2024.



Originally published at https://www.joblo.com/joker-2-wrapped-joaquin-phoenix-lady-gaga-images/

Clone High trailer brings back Phil Lord & Chris Miller’s cult animated series for HBO Max

0
Clone High trailer brings back Phil Lord & Chris Miller’s cult animated series for HBO Max

HBO Max releases Clone High teaser trailer for revival of Phil Lord, Christopher Miller & Bill Lawrence’s cult animated series.

https://www.youtube.com/watch?v=-r0KkiJ7Lsc

Clone High was easily one of my favourite animated shows, but the series was cancelled in 2003 after just thirteen episodes. Now, twenty years later, the clones are back! HBO Max has released the first teaser trailer for the upcoming Clone High revival, which features the return of Abe, Joan, Cleo, JFK, and a few new faces.

The original Clone High series was created by Phil Lord, Christopher Miller, and Bill Lawrence, all of whom have returned for the revival. Dubbed a “modern refresh” of the original series, Clone High is “set at a high school for clones of historical figures. After a high school that was secretly being run as an elaborate military experiment to clone the greatest minds in history was put on ice, the clones have been thawed out 20 years later to resume the experiment with new clone classmates – all while navigating a new set of cultural norms and overly dramatic teen relationships.

The returning cast includes Will Forte as Abe, Nicole Sullivan as Joan, Phil Lord as Scudworth, Chris Miller as JFK and Mr. B, Donald Faison as George Washington Carner, and Judah Miller as Scangrade. Christa Miller, who voiced Cleo in the original series, will instead voice Candide Sampson. The role of Cleo has now been filled by Mitra Jouhari. The rest of the new cast includes Ayo Edebiri as Harriet, Vicci Martinez as Frida, Kelvin Yu as Confucious, Neil Casey as Topher Bus, Jana Schmieding as Sacagawea, Sam Richardson as Wesley, Mo Gaffney as Ms. Grumbles, Al Madrigal as Frederico; Danny Pudi as Dr. Neelankavil, Emily Maya Mills as Ethel Merman, Michael Bolton as Michael Bolton, Mandy Moore as Mandy Moore, Ian Ziering as Ian Ziering, and Steve Kerr as Steve Kerr.

You might notice that one of the original Clone High characters is not featured in the revival. Of course, I’m talking about Gandhi. The character sparked protests in India, as they were outraged by the show’s depiction of the real-life figure. In an apology at the time, MTV said, “Clone High was created and intended for an American audience… we recognize and respect that various cultures may view this programming differently, and we regret any offence taken by the content in the show.

Clone High will premiere this spring on HBO Max. What did you think of the Clone High trailer?

Originally published at https://www.joblo.com/clone-high-trailer-hbo-max/

Super Mario Bros. now tracking $127.5 million five-day opening

0
Super Mario Bros. now tracking 7.5 million five-day opening

Let’s-a go to the movies! Box office projections are expecting the Super Mario Bros. Movie to have one of Illumination’s best openings.

The box office haul for The Super Mario Bros. Movie is projected to be $127.5 million over its five-day opening, throwing a blue shell at previous estimates, which put it between $85-$90 million. Breaking it down, Wednesday–its official opening day–was looking at $26 million alone, while the three-day total is shaping up to be just over $86 million.

These box office numbers would make The Super Mario Bros. Movie the second-best five-day opening for Illumination, following 2013’s Despicable Me 2. While Pixar and Disney are still the kings of box office when it comes to animated features, Illumination has been making its presence known for over a decade now, with the Despicable Me franchise actually being one of the highest-grossing animated franchises ever. Through its five entries, it has raked in nearly $1.6 billion, topping even Toy Story (albeit with only four entries). Ahead of The Super Mario Bros. Movie, Illumination has a worldwide take of just over $8 billion, with much credit going to the minions.

Deadline notes that the current champ of a three-day opening for a movie based on a video game is Sonic the Hedgehog 2 with $72.1 million. This would set up a Super Smash Bros. showdown at the box office this week, with Mario easily coming out on top of the blue speed demon.

Mario, Luigi, Peach, and Toad aren’t looking at much competition at the box office over the weekend. Ben Affleck’s Air (read our 8/10 review here), which chronicles the development and success of the Air Jordan sneaker, hits an entirely different demographic and is looking at around $16 million. Dungeons & Dragons: Honor Among Thieves is expected to drop from its $37.2 opening but still hold onto the number two spot.

Will you be gassing up the go-kart and upping Mario and company’s box office numbers? How do you think the movie will do over the weekend? Let us know below!

Originally published at https://www.joblo.com/super-mario-bros-now-tracking-127-5-million-five-day-box-office/

Beverly Hills Hair Restoration’s Dr. John Kahen, MD, Has Been Awarded a Patent for SmartPRP, a Groundbreaking Therapy for Hair Restoration

0
Beverly Hills Hair Restoration’s Dr. John Kahen, MD, Has Been Awarded a Patent for SmartPRP, a Groundbreaking Therapy for Hair Restoration

Dr. John Kahen has recently announced the issuance of a U.S. patent (no. 10,456,422-B2) for his Smart PRP® (Platelet-Rich Plasma) therapy, a revolutionary solution for hair restoration surgery. This patented remedy involves healing the surgical wound from the transferred hair follicles, which should result in a high survival rate for the hair follicle graft. The SmartPRP therapy utilizes the body's own tissue to stimulate fresh follicles, promoting natural hair color and density while improving scarring for a more organic healing process.

Dr. Kahen is a world-renowned hair transplant specialist who has performed thousands of hair transplant procedures, including for many celebrities and international clients. His scientific approach is the new state-of-the-art technique for hair restoration.

"I have been using SmartPRP exclusively during my hair transplant procedures for over a decade," states Dr. Kahen. "The infusion of platelet-rich plasma has increased the survival rate of the follicles and expedited the healing process, resulting in thicker, more voluminous, and stronger and healthier hair for my patients."

Smart PRP therapy is a quick 30-minute procedure performed on-site at Dr. Kahen's practice facility in Beverly Hills, California, with no downtime for patients, allowing them to resume their regular activities immediately after treatment.

About Dr. John Kahen

Dr. Kahen is a world-renowned hair transplant specialist located in Beverly Hills, California. Dr. Kahen entered private practice exclusively as a hair restoration surgeon in 2007, proudly retaining membership with the International Society of Hair Restoration Surgery. Dr. Kahen created SmartPRP® to achieve impeccable hair restoration results. Dr. Kahen garnered massive respect from the plastic surgeon community, winning the "Aesthetic Award" for three consecutive years. Dr. Kahen's expertise in the science of hair restoration has made him the most sought-out hair restoration expert in the profession. For more information, visit www.beverlyhillshr.com or follow along on FacebookTwitter, and Instagram.

About Beverly Hills Hair Restoration (BHHR)

Beverly Hills Hair Restoration (BHHR) is a world-class clinic committed to enlightening our patients' despair from hair loss, with groundbreaking surgical and non-surgical practices. Our clinic is the pioneer of PRP for hair restoration and one of the first in the world to rejuvenate follicles with that system. We have revolutionized Platelet Rich Plasma (PRP) stem cell technologies such as SmartPRP®, which has afforded our clients with unmatched hair loss solutions. For more information or appointments, visit www.beverlyhillshr.com, and follow along on FacebookInstagram, and Twitter.

Contact Information:
Media Beverly Hills PR
[email protected]


Original Source: Beverly Hills Hair Restoration's Dr. John Kahen, MD, Has Been Awarded a Patent for SmartPRP, a Groundbreaking Therapy for Hair Restoration